# Premature Thelarche and Adrenarche > Premature thelarche and adrenarche for NEET-PG Paediatrics: benign variants, LH cut-offs, bone age, 17-OHP testing and when to worry. - Canonical URL: https://prepelephant.com/topics/neet-pg/paediatrics/premature-thelarche-and-adrenarche - Exam / course: NEET-PG · Subject: Paediatrics - Publisher: PrepElephant (https://prepelephant.com) — Prepared and reviewed by the PrepElephant Academic Review Team - First published: 2026-10-02 - Last updated: 2026-10-02 - How to cite: "Premature Thelarche and Adrenarche", PrepElephant, https://prepelephant.com/topics/neet-pg/paediatrics/premature-thelarche-and-adrenarche ## Direct answer Premature thelarche and premature adrenarche are the two benign "partial puberty" variants in which a single element of puberty — breast buds in thelarche (girls under 8 years), pubic or axillary hair with apocrine odour in adrenarche (girls under 8, boys under 9) — appears without the rest, and the clinical task is to prove them benign by excluding true central precocious puberty and androgen-excess disorders. The defining profile of premature thelarche is a non-progressive breast bud with prepubertal gonadotrophins (basal LH below about 0.3 IU/L), no growth acceleration, no pubic hair and a bone age concordant with chronological age; premature adrenarche shows pubic hair with prepubertal gonadotrophins, mildly elevated DHEAS, and normal 17-hydroxyprogesterone excluding non-classic congenital adrenal hyperplasia. Both are managed with reassurance and six-monthly review, watching for the minority who cross into true precocity. ## What you must remember - **Definitions to state precisely:** premature thelarche — isolated breast development (Tanner stage 2 or more) before 8 years without other secondary sexual characteristics; premature adrenarche — isolated pubic or axillary hair with apocrine odour before 8 years in girls or 9 years in boys. - **Thelarche phenomenology:** two peaks — the neonatal (maternal oestrogen withdrawal) and the classic toddler-to-preschool presentation between 6 months and 3 years; typically bilateral but asymmetrical, with preserved nipple-areolar immaturity, no growth spurt, no vaginal bleeding, no pubic hair. - **The LH rule:** a basal LH below about 0.3 IU/L supports a benign variant; a basal LH above 0.3 to 0.5, or a GnRH-stimulated LH peak above 5 to 6 IU/L, declares central activation — the single most useful laboratory divider. Concordant supporting evidence: a prepubertal (tubular) uterus on pelvic ultrasound and a bone age equal to chronological age; advanced bone age with height acceleration reframes the case toward true puberty. - **Adrenarche biology:** the adrenal zona reticularis awakens and secretes DHEA and DHEAS — adrenal androgens, not gonadal; commoner in obese children (insulin drives adrenal androgen output); testicular volume stays prepubertal in boys, the bedside proof against central puberty. - **The crossover warnings:** follow every child six-monthly for height velocity, breast or testicular progression and bone age; thelarche before 2 to 3 years usually regresses, but thelarche appearing after 6 years, or adrenarche in a thin girl with acanthosis, can herald true precocious puberty or future polycystic ovary syndrome respectively. The mandatory exclusion in adrenarche is non-classic congenital adrenal hyperplasia — a morning 17-hydroxyprogesterone — with tumours excluded by tempo: adrenarche evolves over years, tumours advance over weeks to months with clitoromegaly or phallic enlargement. - **The Indian clinic frame:** obesity-driven premature adrenarche is rising in urban India; and idiopathic central precocious puberty is commoner in adopted and undernourished-then-rapidly-growing children — a demographic examiners occasionally invoke; management of confirmed benign variants is reassurance and surveillance, not pharmacology. ## Two consultations that define the boundary First, a 22-month-old girl with bilateral 2 to 3 cm breast buds, no pubic hair, height tracking along her centile; the mother was told at a camp that "puberty has started". Basal LH returns under 0.3 IU/L, bone age matches chronological age, and the uterus is prepubertal on ultrasound. This is premature thelarche of the classic benign pattern: reassure, review at six months with a growth chart, and give re-contact instructions for vaginal bleeding, rapid growth or pubic hair. Second, a 7-year-old girl with six months of coarse pubic hair and axillary odour, body mass index on the 95th centile with acanthosis; 17-hydroxyprogesterone is normal, DHEAS mildly elevated for stage, bone age advanced by one year. This is premature adrenarche on an insulin-resistance background — reassure about the pubertal process itself, but use the visit as preventive medicine: weight management, activity, and long-term vigilance for polycystic ovary syndrome, because this phenotype is the childhood face of a metabolic trajectory. ## How the exam frames it The core question is boundary-drawing: isolated thelarche versus central precocious puberty — answered by growth velocity, basal LH, uterine ultrasound and bone age, with basal LH the usual single best discriminator offered. The second is adrenarche's mandatory exclusion — non-classic CAH via morning 17-hydroxyprogesterone — with the tumour tempo rule (months versus years) as the viva follow-up. The age thresholds (8 years girls, 9 years boys) are quoted in nearly every stem, and the subtle mark lies in the exceptions: isolated menarche before 8, and thelarche with accelerated growth, both of which push evaluation toward true puberty or an ovarian source rather than reassurance. ## Frequently asked questions ### What defines premature thelarche? Isolated breast development before 8 years in a girl, without pubic hair, growth acceleration, vaginal bleeding or other secondary sexual characteristics. ### Which single laboratory value best separates premature thelarche from central precocious puberty? A basal LH below about 0.3 IU/L supports a benign variant; values above this (or a GnRH-stimulated peak above 5 to 6 IU/L) indicate central activation. ### Which investigation is mandatory in premature adrenarche? A morning 17-hydroxyprogesterone to exclude non-classic congenital adrenal hyperplasia, alongside tempo assessment and androgen markers. ### Why is premature adrenarche commoner in obese children? Insulin resistance and hyperinsulinaemia stimulate adrenal androgen secretion, so adiposity both triggers and amplifies adrenarche. ### What follow-up is advised for a child with a benign puberty variant? Six-monthly review of height velocity and progression of breast or pubic hair, watching for crossover into true precocity.